Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - AccuMed International (OTC BB:ACMI.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Financials
Location
920 North Franklin Street, Suite 402
Chicago, IL 60610
Phone: (312) 642-9200
Fax: (312) 642-3492
Email: info@accumed.com
Employees (last reported count): 4
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 48%
·Institutional: 0% (0% of float)
(2 institutions)
·Net Inst. Buying: 11.0K shares (+49.95%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
AccuMed International, Inc. designs, builds and supplies two product lines. The first product line consists of AcCells computer-aided microscopes, which help medical experts to examine and diagnose specimens of human cells. The second product line consists of AcCell-Savant. The AcCell-Savant includes all the AcCell components, as well as an electronic imaging system and the Company's image analysis software.
More from Market Guide: Expanded Business Description

Financial Summary
ACMI is a global advanced diagnostics and information solutions company. ACMI develops and markets cytology and histology products that improve the quality of cell-based specimen analysis. For the six months ended 6/01, revenues totalled $759 thousand, up from $239 thousand. Net loss declined 37% to $1.1 million. Revenues benefited from a $491 thousand licensing agreement with Monogen, Inc. Lower loss reflects reduced personnel, administrative and R&D expenses.
More from Market Guide: Significant Developments

Officers
FY1999 Pay

Paul Lavallee, 60
Chairman and CEO
$360K
Norman Pressman Ph.D., 52
Pres and CSO
319K
Jack Halperin, 54
Director and Sec.
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ACMI.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 28-Dec-2000
$0.031
Recent Price$0.39 
52-Week High
on 26-Sep-2000
$1.00 
Beta2.77 
Daily Volume (3-month avg)14.3K
Daily Volume (10-day avg)19.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-30.7%
52-Week Change
relative to S&P500
-7.1%
Share-Related Items
Market Capitalization$2.24M
Shares Outstanding5.74M
Float3.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.21 
Earnings (ttm)-$0.43 
Earnings (mrq)-$0.10 
Sales (ttm)$0.17 
Cash (mrq)$0.07 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)2.24 
Income Statements
Sales (ttm)$996.0K
EBITDA (ttm)-$1.62M
Income available to common (ttm)-$2.46M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-40.43%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.37 
Debt/Equity (mrq)1.31 
Total Cash (mrq)$400.0K
Short Interest
As of 10-Nov-2000
Shares Short0 
Shares Short
(Prior Month)
1,000 
Daily Volume13.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.